CureVac
Carolin Teucher is a Senior Scientist in Process Development Drug Product at CureVac since December 2021, previously serving as a Scientist in the same department. Prior to CureVac, Carolin worked as a Project Manager in Research and Development at Catalent Pharma Solutions from October 2020 to November 2021. Between October 2015 and September 2020, Carolin held the position of Application Scientist at JRS PHARMA, focusing on the development of Ready to Use Coatings and tablet excipients. Early career experiences include an internship as a Pharmacist at a pharmacy, where responsibilities included customer consultation and the planning and documentation of a proprietary bitter formulation, as well as a role as a Diplomand in Pharmaceutical Technology at Eberhard Karls Universität Tübingen, where the focus was on the stability optimization of specialized emulsions. Carolin holds a degree in Pharmacy from the University of Tübingen, awarded in December 2014, which includes professional qualification as a licensed pharmacist.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.